Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 3 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
The emerging role of RNA N6-methyladenosine methylation in breast cancer.
Biomark Res. 2021 May 27;9(1):39. doi: 10.1186/s40364-021-00295-8.
Biomark Res. 2021.
PMID: 34044876
Free PMC article.
Review.
Expression and clinical prognostic value of m6A RNA methylation modification in breast cancer.
Zheng F, Du F, Qian H, Zhao J, Wang X, Yue J, Hu N, Si Y, Xu B, Yuan P.
Zheng F, et al.
Biomark Res. 2021 Apr 29;9(1):28. doi: 10.1186/s40364-021-00285-w.
Biomark Res. 2021.
PMID: 33926554
Free PMC article.
Item in Clipboard
Disease-free survival landmark analysis: a potential critical endpoint in triple-negative breast cancer.
Zheng F, Wei T, Wang X, Du F, Yue J, Yuan P.
Zheng F, et al.
Exp Hematol Oncol. 2022 Sep 27;11(1):65. doi: 10.1186/s40164-022-00308-8.
Exp Hematol Oncol. 2022.
PMID: 36167566
Free PMC article.
Item in Clipboard
Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer.
Ju J, Du F, Gao SL, Si YR, Hu NL, Liu DX, Wang X, Yue J, Zheng FC, Kang YK, Yang ZX, Ma F, Xu BH, Yuan P.
Ju J, et al.
Breast Cancer Res Treat. 2022 Jul;194(2):221-230. doi: 10.1007/s10549-022-06629-w. Epub 2022 Jun 14.
Breast Cancer Res Treat. 2022.
PMID: 35699854
Item in Clipboard
Updated efficacy of adjuvant epirubicin plus cyclophosphamide followed by taxanes versus carboplatin plus taxanes in early triple-negative breast cancer in phase 2 trial: 8.1-year median follow-up.
Zheng F, Du F, Wang W, Wang Y, Li M, Zhao J, Wang X, Yue J, Wang J, Yang Z, Cai R, Ma F, Fan Y, Li Q, Zhang P, Xu B, Yuan P.
Zheng F, et al.
Breast Cancer Res Treat. 2022 Jan;191(1):97-105. doi: 10.1007/s10549-021-06401-6. Epub 2021 Oct 14.
Breast Cancer Res Treat. 2022.
PMID: 34648118
Clinical Trial.
Item in Clipboard
Cite
Cite